- Home
- SANG vs GNFT Comparison
SANG vs GNFT Comparison
Compare SANG & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- GNFT
- Stock Information
- Founded
- SANG 1984
- GNFT 1999
- Country
- SANG Canada
- GNFT France
- Employees
- SANG N/A
- GNFT N/A
- Industry
- SANG Computer Software: Programming Data Processing
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SANG Technology
- GNFT Health Care
- Exchange
- SANG Nasdaq
- GNFT Nasdaq
- Market Cap
- SANG 213.1M
- GNFT 186.3M
- IPO Year
- SANG 2021
- GNFT 2019
- Fundamental
- Price
- SANG $5.79
- GNFT $3.99
- Analyst Decision
- SANG
- GNFT Strong Buy
- Analyst Count
- SANG 0
- GNFT 1
- Target Price
- SANG N/A
- GNFT $13.00
- AVG Volume (30 Days)
- SANG 1.5K
- GNFT 4.0K
- Earning Date
- SANG 09-17-2025
- GNFT 09-18-2025
- Dividend Yield
- SANG N/A
- GNFT N/A
- EPS Growth
- SANG N/A
- GNFT N/A
- EPS
- SANG N/A
- GNFT 0.03
- Revenue
- SANG $238,264,000.00
- GNFT $73,187,701.00
- Revenue This Year
- SANG N/A
- GNFT $5.15
- Revenue Next Year
- SANG $2.38
- GNFT N/A
- P/E Ratio
- SANG N/A
- GNFT $133.57
- Revenue Growth
- SANG N/A
- GNFT 105.01
- 52 Week Low
- SANG $4.08
- GNFT $2.55
- 52 Week High
- SANG $7.99
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- SANG 49.85
- GNFT 53.56
- Support Level
- SANG $5.58
- GNFT $3.71
- Resistance Level
- SANG $5.86
- GNFT $4.20
- Average True Range (ATR)
- SANG 0.11
- GNFT 0.16
- MACD
- SANG 0.02
- GNFT 0.02
- Stochastic Oscillator
- SANG 76.56
- GNFT 60.23
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.